Congenital Diaphragmatic Hernia

Download as ppt, pdf, or txt
Download as ppt, pdf, or txt
You are on page 1of 40

CONGENITAL

DIAPHRAGMATIC HERNIA

Man Mohan Harjai


OVERVIEW
•Background
•Pathophysiology
•Management
•New Advances
BACKGROUND
•1597 first described
•1925 literature review
•1945 CDH repair
INCIDENCE
•1 in 12,00 live births
•Malrotation always present
•Congenital anomalies 23%
EMBRYOLOGY
•Pleuroperitoneal membrane
•Midgut rotation
•Foramen of Bockdalek
•Foramen of Morgagni
•Esophageal hiatus
PULMONARY DEVELOPMENT
•8-10 weeks bronchial buds
•16 weeks segmental bronchi
•24 weeks-5 years alveolar formation
•Growth of blood vessels
DIAGNOSIS
•Decreased chest movement
•Shift of cardiac impulse
•Presence of bowel sounds
•Scaphoid abdomen
DIAGNOSIS
•Cyanosis
•Respiratory distress
•X-ray findings
PULMONARY HYPOPLASIA
•Animal model
•Decreased parenchymal mass
•Reduced surface area
•Reduced pulmonary vasculature
VASCULAR HYPERTROPHY

•Thickened pulmonary and arteriolar media


•Extension muscle to resistance vessels
•Increased response to hypoxemia and acidosis
VASCULAR HYPERTROPHY
•Bonn
•> 1/3 alveolar wall vessels muscularized
•> 2X normal medial wall thickness
POSTNATAL PHYSIOLOGY
•Underdeveloped parenchyma
•Underdeveloped vascular bed
•Hypertrophied resistance vessels
PREDICTORS OF MORTALITY
•Collins 1977 "Honeymoon period"
•Preductal PaO2 > 100 PaCO2 < 50
•Adequate pulmonary parenchyma
•90% likelihood of death
PREDICTORS OF MORTALITY
•Barlett
•Integrated FIO2 and pH
•Newborn Pulmonary Insufficiency Index
PREDICTORS OF MORTALITY

•O'Rouke
•Postductal PaO2 >100
PREDICTORS OF MORTALITY
•Raphaely and Downs
•Prognostic test after closure
•A-a02
PREDICTORS OF MORTALITY
•Oxygen Index
•Based on MAP
•Postductal O2 > 100
PREDICTORS OF MORTALITY
•Inconsistent site of sampling
•Inconsistent time to repair
•No ventilatory parameters referenced
•Integration pulmonary hypertension/hypoplasia
PREDICTORS OF MORTALITY
•Bohn
•Integrated PaCO2 and Ventilatory Index
•Four survival groups
•Inconsistent use
DELAYED SURGICAL REPAIR
•Original surgical therapy
•Respiratory/cardiovascular function
•Langer 1984 advocated delay
•Preoperative improvement
DELAYED SURGICAL REPAIR
•Partial reduction possible
•Not atelectasis but hypoplasia
•Repair often decreased thoracic compliance
MANAGEMENT
•Controlled ventilation
•Fluid resuscitation
•IV access
•Arterial line
•Central line
MANAGEMENT
•Narcotic-02-relaxant
•Avoid N20
•Inhalational agents
•Abrupt decay
MANAGEMENT
•Hypoxemia,hypercarbia,acidosis,hypothermia
•IVC compression
•Patch?
•Prolonged anesthetic state
•< 50% survival with repair
RECENT ADVANCES
•Postnatal management
•Prenatal repair
•Perinatal lung transplant
METHOD OF VENTILATION
•HFOV
•Decreased A-a02 gradient
•Decreased FI02/PaC02
•Lower airway pressure
ECMO
•Barlett 1972
•Neonatal respiratory failure
•Flows 100-120 ml/kg/min
•Preductal Pa02 80-100
•PaC02 30-45
ECMO
•Limit airway pressure
•Limit oxygen toxicity
•Eliminate shunting
•Reverse systemic hypoxemia
•Reduce pulmonary blood flow
•Allow gradual expansion of lung
ECMO

•Complications
•Contraindications
ECMO
•Stolar
•Demise of "Honeymoon period"
•Stimulation of sympathoadrenal axis
ECMO
•O'Rouke
•Weaning to CMV
•Changed survival high risk CDH
REPAIR DURING ECMO
•Hematocrit > 40
•Platelets 50-100 K
•Heparin
•Colloid/crystalloid
•Ventilation
•Narcotic infusion
•Venous return
RECENT ADVANCES
•77% mortality for prenatal diagnosis
•Pulmonary hypoplasia difficult to assess
•Dismal prognosis
PRENATAL REPAIR
•Harrison
•Fetal lamb model
•Critical time growth/development
•Placental bypass
PRENATAL REPAIR
•Successful intrauterine repair
•Criteria for consideration
•Best conditions 22-30 weeks
PRENATAL REPAIR
•Operative management
•Maternal complications
•Gortex implant
LUNG TRANSPLANT
•Adzick
•Transplant as potential treatment
•ECMO as bridge until surgery
•LLL transplant in neonatal swine
LONG TERM SURVIVAL
•10% mental retardation
•Pulmonary hypoperfusion
•Pulmonary function testing
•Pulmonary disability in adulthood?
LONG TERM SURVIVAL
•Falconer
•Pectus/scoliosis
•V/Q mismatch
•Overdistention
•Gastroesophageal dismotility
CONCLUSION
•Continued morbidity/mortality
•New strategies
•Ongoing research
•Cost
•New etiology?

You might also like